期刊文献+

冻干血浆在战创伤失血性休克救治中的应用研究进展 被引量:3

Application progress of freeze-dried plasma in the treatment of hemorrhagic shock in civilian and military trauma
在线阅读 下载PDF
导出
摘要 失血性休克是战创伤患者伤后早期的主要死亡原因,及早输注血浆可有效提高战创伤失血性休克患者的存活率。冻干血浆(FDP)与新鲜冰冻血浆(FFP)的成分基本相同,在战创伤失血性休克患者的救护中具有良好的临床效果,同时其在储存、运输等后勤保障中具备优势,无论是在战时或平时的创伤救治中都能够确保伤员得到及时有效的液体复苏,提升战创伤伤员的救治水平。本文拟从FDP的研究状况、临床应用效果及使用优势方面做系统分析,以期为FDP在战创伤失血性休克患者的救治提供参考。 Hemorrhagic shock is the main cause of death in the early stage of civilian and military trauma.Early plasma infusion could improve the survival rate of patients with hemorrhagic shock in civilian and military trauma.The components of freeze-dried plasma(FDP)are basically the same as that of fresh frozen plasma(FFP),and it has good effect on the rescue of patients with hemorrhagic shock in civilian and military trauma.Meanwhile,it has advantages in storage and transportation.In the rescue of civilian and military trauma,FDP ensures the casualties timely and effective fluid resuscitation,and improve the rescue level of civilian and military trauma.Our study reviewed the current status of research,clinical application and advantages of FDP,aiming to provide information for the rescue of casualties with traumatic hemorrhagic shock.
作者 陆红祥 古丽努尔·库尔班 文爱清 Lu Hongxiang;Gulinuer Kuerban;Wen Aiqing(Department of Traumatic Orthopaedics,General Hospital of Xinjiang Military Region,Urumqi 830000,China;War Trauma Medical Center,Daping Hospital,Army Medical University,Chongqing 400042,China;Department of Transfusion,General Hospital of Xinjiang Military Region,Urumqi 830000,China;Department of Transfusion,Daping Hospital,Army Medical University,Chongqing 400042,China)
出处 《创伤外科杂志》 2022年第2期96-99,106,共5页 Journal of Traumatic Surgery
基金 国家自然科学基金(81770195)。
关键词 失血性休克 战创伤 冻干血浆 hemorrhagic shock civilian and military trauma freeze-dried plasma
  • 相关文献

参考文献4

二级参考文献19

  • 1钱开诚.血液成分病毒灭活研究的进展.中国输血杂志,2004,17:36-36.
  • 2Espfndola OM, Belluci MS, Oliveira BC, et al. Sindbis virus as a tool for quality controt of viral inactivation of heated and chemically treated plasma-derived products. J Virol Methods, 2006, 134(1-2) :171-175.
  • 3Homsey VS, Drummond O, Young D, et al. A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system. Transfus Med, 2001, 11 (1) :31-36.
  • 4Pieters M, Jerling JC, Weisel JW. Effect of freeze-drying, freezing and frozen storage of blood plasma on fibrin network characteristics. Thromb Res,2002 Sep 1 ; 107 (5) : 263-269.
  • 5Shuja F, Shults C, Duggan M, et al. Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma,2008, 65 (5) :975-985.
  • 6Spoerke N, Zink K, Cho SD, et al. Lyophilized plasma for resuscitation in a swine model of severe injury. Arch Surg,2009 , 144(9) :829-834.
  • 7Segura A, Leon G, Su CY, et al. Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine anti venom A. Biologicals, 2009, 37 (5) : 306-312.
  • 8Chandra S, Groener A, Feldman F. Effectiveness of alternative treatments for reducing potential viral contaminants from plasmaderived products. Thromb Res, 2002, 105 (5) :391-400.
  • 9Bertolini J, Goss N, Curling J. Production of plasma proteins fortherapeutic use [ M ]. Hoboken,New Jersey : John Wiley &Son, Inc. ,2013.
  • 10Zhang JG. Blood support system and management in military op-erations of multinational forces [ C ] . 37th World Congress on Mil-itary Medicine, Tunis, Tunisia, May 20 -25,2007, p36.

共引文献120

同被引文献24

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部